Aceclofenac Sustained-Release 200 mg Film-Coated Tablet

Aceclofenac Sustained-Release 200 mg Film-Coated Tablet is a sustained-release film-coated tablet formulated with 200 mg. The active ingredient profile is Aceclofenac, placing the product in the nsaid / analgesic anti-inflammatory category. The formulation contains an NSAID and/or non-opioid analgesic component intended to reduce pain and inflammatory symptoms when clinically appropriate. The modified-release designation indicates a controlled release presentation and must be described and administered exactly as stated in the approved product literature. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.